• Title/Summary/Keyword: Vaccine strategy

Search Result 89, Processing Time 0.03 seconds

A Study on the Development of the Advertising Strategy and Public Service Announcement Materials for National Immunization (예방접종 홍보광고 전략개발 조사연구)

  • Oh, Kuk-Hwan;Lee, Moo-Sik;Kim, Byung-Hee;Na, Baeg-Ju;Kim, Keon-Yup;Hong, Jee-Young;Kim, Young-Taek;Go, Jae-Young;Kim, Young-Suk;Lee, Seok-Gu;Cho, Hyung Won
    • Journal of agricultural medicine and community health
    • /
    • v.30 no.2
    • /
    • pp.183-204
    • /
    • 2005
  • Objectives: Immunization program is essential public health service under the national responsibility. One of the immunization service of national immunization program is advertising and public relation service, but research for that was rarely conducted. Therefore we conducted the survey for developing advertising strategy of immunization program in 21th century. Methods: Our study subjects were 242 health workers in immunization service department of 169 health centers and 1,193 carers who visited community health center for receiving immunization service of their children. The major questions were general characteristics of the subjects, perceived importance of immunization program, experience of advertising, knowledge and perception about immunization, and items about advertising strategy. Results: Frequently exposed materials in both health workers and carers were TV, community newspapers, and pamphlets. Health workers had high professional knowledges of immunization and carers had high perceptions for need and importance of immunization. Health workers preferred pamphlets and posters as advertising materials and carerers preferred TV and community newspapers. Both health workers and carers preferred green and yellow as advertising posters' color, active and healthy style of immunization advertising, and positive messages of campaign's slogans. Conclusions: Further researches should be conducted for precising long-term immunization advertising strategy in 21th century, and for this we need to develop advertising materials based on public needs and strategy, and evaluate the materials. The national immunization program should be activated throughout more investment of the budgets and human powers.

  • PDF

Efficacy of Genetic Adjuvant (Plasmid-Expressed Chicken Interleukin-6) and Chemical Adjuvant (Levamisole) on the Protective Immunity of Genetic Vaccine against Infectious Bursal Disease Virus (닭의 전염성 F낭병 바이러스 유전자백신에 의한 방어 면역에 Genetic Adjuvant (Chicken Interleukin-6)와 Chemical Adjuvant (Levamisole)의 효과)

  • Park, Jeong-Ho;Sung, Haan-Woo;Yoon, Byung-Il;Pak, Son-Il;Kwon, Hyuk-Moo
    • Korean Journal of Microbiology
    • /
    • v.45 no.2
    • /
    • pp.91-98
    • /
    • 2009
  • Infectious bursal disease (IBD) caused by the infectious bursal disease virus (IBDV) has an important economic impact on the poultry industry worldwide. This study examined the adjuvant effects of a plasmid encoding chicken interleukin-6 (pcDNA-ChIL-6) and levamisole (LMS) on in ovo prime-boost vaccination using a genetic vaccine (pcDNA-VP243) to prime in chicken followed by a killed-vaccine boost. A pcDNA-VP243 was injected into the amniotic sac alone or in combination with a pcDNA-ChIL-6 or LMS at embryonation day 18, followed by an intramuscular injection of killed IBD vaccine at 1 week of age. The chicken were orally challenged with very virulent IBDV (vvIBDV) strain at 3 weeks of age and observed for 10 days. No mortality was observed in the groups that received the pcDNA-VP243 alone and pcDNA-VP243 plus pcDNA-ChIL-6 or LMS compared to 100% mortality in unvaccinated challenge control group. However, as determined by bursal damage (the presence of IBDV RNA, B/B ratio, and lesion score), a pcDNA-VP243 alone group was superior to pcDNA-VP243 plus pcDNA-ChIL-6 or LMS groups in the protection against post-challenge. These findings suggest that in ovo priming with genetic vaccine and boosting with killed vaccine is an effective strategy for protecting chicken against vvIBDV and the addition of pcDNA-ChIL-6 or LMS did not enhance protective immunity.

OPTIMAL CONTROL STRATEGY TO COMBAT THE SPREAD OF COVID-19 IN ABSENCE OF EFFECTIVE VACCINE

  • BISWAS, M.H.A.;KHATUN, M.S.;ISLAM, M.A.;MANDAL, S.;PAUL, A.K.;ALI, A.
    • Journal of applied mathematics & informatics
    • /
    • v.40 no.3_4
    • /
    • pp.633-656
    • /
    • 2022
  • Many regions of the world are now facing the second wave of boomed cases of COVID-19. This time, the second wave of this highly infectious disease (COVID-19) is becoming more devastating. To control the existing situation, more mass testing, and tracing of COVID-19 positive individuals are required. Furthermore, practicing to wear a face mask and maintenance of physical distancing are strongly recommended for everyone. Taking all these into consideration, an optimal control problem has been reformulated in terms of nonlinear ordinary differential equations in this paper. The aim of this study is to explore the control strategy of coronavirus-2 disease (COVID-19) and thus, minimize the number of symptomatic, asymptomatic and infected individuals as well as cost of the controls measures. The optimal control model has been analyzed analytically with the help of the necessary conditions of very well-known Pontryagin's maximum principle. Numerical simulations of the optimal control problem are also performed to illustrate the results.

Construction of recombinant DNA clone for bovine viral diarrhea virus (소 바이러스성 설사병 바이러스의 유전자 재조합 DNA clone의 작성에 관한 연구)

  • Yeo, Sang-geon;Cho, H.J.;Masri, S.A.
    • Korean Journal of Veterinary Research
    • /
    • v.32 no.3
    • /
    • pp.389-398
    • /
    • 1992
  • Molecular cloning was carried out on the Danish strain of bovine viral diarrhea virus(BVDV) to construct strategy for the diagnostic tools and effective vaccine of BVD afterwards. A recombinant DNA clone(No. 29) was established successfully from cDNA for viral RNA tailed with adenine homopolymer at 3'-end. $^{32}P$-labeled DNA probes of 300~1,800bp fragments, originating from the clone 29, directed specific DNA-RNA hybridization results with BVDV RNA. Recombinant DNA of the clone 29 was about 5,200bp representing 41.6% of the full length of Danish strain's RNA, and restriction sites were recognized for EcoR I, Sst I, Hin d III and Pst I restriction enzymes in the DNA fragment.

  • PDF

Group B Streptococcal Disease in Korean Neonates (한국 신생아에서 B군 사슬알균 감염증)

  • Oh, Chi Eun
    • Pediatric Infection and Vaccine
    • /
    • v.19 no.2
    • /
    • pp.43-54
    • /
    • 2012
  • Group B streptococcus (GBS) is the leading cause of neonatal sepsis and meningitis in developed countries. This article reviews the neonatal invasive GBS disease, maternal GBS colonization, and prevention strategies in the context of recent epidemiological changes in Korea. Although Korean neonates had been supposed to have low incidence of invasive GBS disease, GBS has been recently reported to be the most common cause of invasive neonatal infection after 1990s. Among Korean pregnant women, GBS carriage rate in the vagina and rectum has been reported to be much lower than that in Western countries. However, it has increased in recent studies. For decision making about preventive strategy for neonatal GBS disease in Korea, further studies are required in terms of the incidence of neonatal GBS infection and serotype distribution. In addition, studies about maternal carriage rate and serotype distribution have to be continued.

  • PDF

Foot-and-mouth disease: overview of motives of disease spread and efficacy of available vaccines

  • Saeed, Ali;Kanwal, Sehrish;Arshad, Memoona;Ali, Muhammad;Shaikh, Rehan Sadiq;Abubakar, Muhammad
    • Journal of Animal Science and Technology
    • /
    • v.57 no.4
    • /
    • pp.10.1-10.7
    • /
    • 2015
  • Control and prevention of foot and mouth disease (FMD) by vaccination remains unsatisfactory in endemic countries. Indeed, consistent and new FMD epidemics in previously disease-free countries have precipitated the need for a worldwide control strategy. Outbreaks in vaccinated animals require that a new and safe vaccine be developed against foot and mouth virus (FMDV). FMDV can be eradicated worldwide based on previous scientific information about its spread using existing and modern control strategies.

A Promising Vaccination Strategy against COVID-19 on the Horizon: Heterologous Immunization

  • Mattoo, Sameer-ul-Salam;Myoung, Jinjong
    • Journal of Microbiology and Biotechnology
    • /
    • v.31 no.12
    • /
    • pp.1601-1614
    • /
    • 2021
  • To overcome the ongoing COVID-19 pandemic, vaccination campaigns are the highest priority of majority of countries. Limited supply and worldwide disproportionate availability issues for the approved vaccines, together with concerns about rare side-effects have recently initiated the switch to heterologous vaccination, commonly known as mixing of vaccines. The COVID-19 vaccines are highly effective in the general population. However, none of the vaccines is 100% efficacious or effective, with variants posing more challenges, resulting in breakthrough cases. This review summarizes the current knowledge of immune responses to variants of concern (VOC) and breakthrough infections. Furthermore, we discuss the scope of heterologous vaccination and future strategies to tackle the COVID-19 pandemic, including fractionation of vaccine doses and alternative route of vaccination.

Phylogenetic Analysis of Bovine Viral Diarrhea Virus from Korean Indigenous Calves in Gyeongbuk Province (경북지역에서 사육되고 있는 한우 송아지에서 소 바이러스성 설사 바이러스의 계통발생 분석)

  • Song, Moo-Chan;Choi, Kyoung-Seong
    • Journal of Veterinary Clinics
    • /
    • v.27 no.6
    • /
    • pp.635-639
    • /
    • 2010
  • The prevalence of bovine viral diarrhea virus (BVDV) in Korean indigenous calves with diarrhea in Gyeongbuk province was investigated. Seventy-five cases were identified as BVDV positive in the diarrhea stools. Phylogenetic analysis revealed that all our cases were classified as BVDV-2a. Most of the present BVDV-2a cases were isolated from calves showing clinical signs of watery diarrhea. Our observations indicate that not all BVDV-2 infections cause clinically severe disease. This study shows the high incidence of BVDV-2 infection in Gyeongbuk province. Therefore, the results suggest that a vaccine development and immunization strategies are required for the effective control of BVDV infection in the Republic of Korea.

Acute porcine reproductive and respiratory syndrome outbreaks in immunized sow herds: from occurrence to stabilization under whole herd vaccination strategy

  • Moon, Sung Ho;Yoo, Sung J.;Noh, Sang Hyun;Kwon, Taeyong;Lee, Dong Uk;Je, Sang H.;Kim, Myung Hyee;Seo, Sang Won;Lyoo, Young S.
    • Korean Journal of Veterinary Research
    • /
    • v.58 no.2
    • /
    • pp.73-79
    • /
    • 2018
  • Outbreaks of porcine reproductive and respiratory syndrome virus (PRRSV) in vaccinated sow herds from occurrence to stabilization were monitored and analyzed in terms of serology and reproductive performance. Three different conventional pig farms experienced severe reproductive failures with the introduction of a type 1 PRRSV. These farms had adopted mass vaccination of sows using a type 2 PRRSV modified live vaccine (MLV). Therefore, to control the type 1 PRRSV, an alternative vaccination program utilizing both type 1 and type 2 MLV was undertaken. Following whole herd vaccinations with both types of MLV, successful stabilization of PRRS outbreaks was identified based on serological data (no viremia and downward trends in ELISA antibody titers in both sows and suckling piglets) and recovery of reproductive performance. Additionally, through comparison of the reproductive parameters between outbreak and non-outbreak periods, it was identified that PRRSV significantly affected the farrowing rate and the number of suckling piglets per litter at all three pig farms. Comparison of reproductive parameters between periods when the different vaccination strategies were applied revealed that the number of piglets born in total and born dead per litter were significantly increased after the introduction of the type 1 PRRS MLV.

Seroprevalence of Anti-EBV IgG among Various Age Groups from Khon Kaen Province, Thailand

  • Suntornlohanakul, Rabporn;Wanlapakorn, Nasamon;Vongpunsawad, Sompong;Thongmee, Thanunrat;Chansaenroj, Jira;Poovorawan, Yong
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.16 no.17
    • /
    • pp.7583-7587
    • /
    • 2015
  • Epstein-Barr virus (EBV) is an extremely common herpesvirus that may cause asymptomatic infection or various diseases, including infectious mononucleosis, certain lymphoproliferative diseases and several types of neoplasms. Vaccine development is an important strategy to reduce the burden of EBV-associated diseases and the timing of vaccinations should be before primary infection occurs. In the past, more than 90% of Thai children were infected with EBV in early childhood. Now, due to the improved healthcare system in Thailand, we aim to determine current prevalence of EBV infection among people in different age groups. A total of 538 sera were collected from residents of Khon Kaen province in northeastern Thailand for detecting anti-EBV IgG. Sera of infants under 2-years-old were also tested for anti-EBV IgM and EBV-DNA. The prevalence of anti-EBV IgG was 47.1% (95% CI: 23.3-70.8) in infants aged 0-6 months, 34.9% (95% CI: 23.1-46.7) in those aged 6-24 months, 87.9% (95% CI: 79.5-96.3) in children aged 3-5 years and then maintained at above 95% through adulthood. These seropositivity rates among Thai children remain similar to those found in a previous study conducted 20 years ago. Thai children are still exposed to EBV from an early age. Therefore, a prophylactic vaccine should be given within the first two years of life.